Injectable vs. Oral GLP-1s: A Complete Comparison
Weekly shot or daily tablet. Here is how they differ on results, cost, and day-to-day experience.
- Semaglutide (Wegovy, Ozempic), tirzepatide (Zepbound, Mounjaro)
- Once weekly
- Avg. 15–21% body-weight loss in trials
- $199–$399/mo compounded; $499+ brand
- Oral semaglutide (Rybelsus), compounded tablets and drops
- Once daily, on an empty stomach
- Smaller average loss; varies by dose
- $149–$299/mo typical
Efficacy
Injectables have the larger evidence base for weight loss and produce bigger average results, particularly tirzepatide. Oral semaglutide was approved for blood-sugar control, and weight loss at those doses is more modest. Higher-dose oral formulations are in late-stage development and are expected to narrow the gap.
Side effects
Both share the same GI profile: nausea, constipation, reduced appetite, occasional fatigue. Injectables concentrate these around dose day; tablets spread them more evenly. Neither is clearly gentler for everyone.
Which programs offer which
Nearly every telehealth program offers injectables. Oral options are less universal, so if you strongly prefer a tablet, that preference narrows your list before price does. Our eligibility check takes format preference into account.
Answer 6 questions and we'll tell you injectable, oral, or neither.
Start the check →This article is informational and not medical advice. A licensed clinician makes every prescribing decision. Medical disclaimer